Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check7 days agoChange DetectedA new Revision: v3.5.5 is added and the previous Revision: v3.5.4 is removed from the history, updating the page’s revision tag. This administrative metadata change does not affect study content, results, or user-facing functionality.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, indicating a newer site build.SummaryDifference0.0%

- Check43 days agoChange DetectedNew latest revision v3.5.3 is added to the history, replacing the previous v3.5.2. This reflects a minor metadata update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision v3.5.2 was added and v3.5.0 was removed in the page's history.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision: v3.5.0 is active on the page, replacing v3.4.3 as part of a site-wide update to the UI and underlying system.SummaryDifference0.0%

- Check93 days agoChange DetectedA new revision entry v3.4.3 was added to the history and the v3.4.2 entry was removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.